Circulating Non-Coding RNA Levels Are Altered in Autosomal Dominant Frontotemporal Dementia
Abstract
:1. Introduction
2. Results
3. Discussion
4. Materials and Methods
4.1. Population
4.2. Serum Samples Collection and Total RNA Isolation
4.3. Screening of miRNAs and lncRNAs in Human Serum Samples
4.4. Statistical Analysis
4.5. Target Prediction and Pathway Enrichment Analysis
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Conflicts of Interest
References
- Pottier, C.; Zhou, X.; Perkerson, R.B.; Baker, M.; Jenkins, G.D.; Serie, D.J.; Ghidoni, R.; Benussi, L.; Binetti, G.; López de Munain, A.; et al. Potential Genetic Modifiers of Disease Risk and Age at Onset in Patients with Frontotemporal Lobar Degeneration and GRN Mutations: A Genome-Wide Association Study. Lancet Neurol. 2018, 17, 548–558. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Rademakers, R.; Hutton, M. The Genetics of Frontotemporal Lobar Degeneration. Curr. Neurol. Neurosci. Rep. 2007, 7, 434–442. [Google Scholar] [CrossRef] [PubMed]
- Bang, J.; Spina, S.; Miller, B.L. Frontotemporal Dementia. Lancet 2015, 386, 1672–1682. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Iyengar, B.R.; Choudhary, A.; Sarangdhar, M.A.; Venkatesh, K.V.; Gadgil, C.J.; Pillai, B. Non-Coding RNA Interact to Regulate Neuronal Development and Function. Front. Cell. Neurosci. 2014, 8, 47. [Google Scholar] [CrossRef]
- Hebert, S.; Wang, W.; Zhu, Q.; Nelson, P. A Study of Small RNAs from Cerebral Neocortex of Pathology- Verified Alzheimer’s Disease, Dementia with Lewy Bodies, Hippocampal Sclerosis, Frontotemporal Lobar Dementia, and Non-Demented Human Controls. J. Alzheimer’s Dis. 2013, 35, 335–348. [Google Scholar] [CrossRef] [Green Version]
- Riva, P.; Ratti, A.; Venturin, M. The Long Non-Coding RNAs in Neurodegenerative Diseases: Novel Mechanisms of Pathogenesis. Curr. Alzheimer Res. 2016, 13, 1219–1231. [Google Scholar] [CrossRef] [Green Version]
- Alaqeel, A.; Abou Al-Shaar, H.; Shariff, R.; Albakr, A. The Role of RNA Metabolism in Neurological Diseases. Balk. J. Med. Genet. 2015, 18, 5–14. [Google Scholar] [CrossRef] [Green Version]
- Müller, M.; Kuiperij, H.B.; Versleijen, A.A.M.; Chiasserini, D.; Farotti, L.; Baschieri, F.; Parnetti, L.; Struyfs, H.; De Roeck, N.; Luyckx, J.; et al. Validation of MicroRNAs in Cerebrospinal Fluid as Biomarkers for Different Forms of Dementia in a Multicenter Study. J. Alzheimer’s Dis. 2016, 52, 1321–1333. [Google Scholar] [CrossRef]
- Sheinerman, K.S.; Umansky, S.R. Circulating Cell-Free MicroRNA as Biomarkers for Screening, Diagnosis and Monitoring of Neurodegenerative Diseases and Other Neurologic Pathologies. Front. Cell. Neurosci. 2013, 7, 150. [Google Scholar] [CrossRef] [Green Version]
- Schneider, R.; McKeever, P.; Kim, T.; Graff, C.; van Swieten, J.C.; Karydas, A.; Boxer, A.; Rosen, H.; Miller, B.L.; Laforce Jr, R.; et al. Downregulation of Exosomal MiR-204-5p and MiR-632 as a Biomarker for FTD: A GENFI Study. J. Neurol. Neurosurg. Psychiatry 2018, 89, 851–858. [Google Scholar] [CrossRef]
- Ng, S.Y.; Johnson, R.; Stanton, L.W. Human Long Non-Coding RNAs Promote Pluripotency and Neuronal Differentiation by Association with Chromatin Modifiers and Transcription Factors. EMBO J. 2012, 31, 522–533. [Google Scholar] [CrossRef] [Green Version]
- Mercer, T.R.; Dinger, M.E.; Sunkin, S.M.; Mehler, M.F.; Mattick, J.S. Specific Expression of Long Noncoding RNAs in the Mouse Brain. Proc. Natl. Acad. Sci. USA 2008, 105, 716–721. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Quan, Z.; Zheng, D.; Qing, H. Regulatory Roles of Long Non-Coding RNAs in the Central Nervous System and Associated Neurodegenerative Diseases. Front. Cell. Neurosci. 2017, 11, 175. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Yang, S.; Yang, H.; Luo, Y.; Deng, X.; Zhou, Y.; Hu, B. Long Non-Coding RNAs in Neurodegenerative Diseases. Neurochem. Int. 2021, 148, 105096. [Google Scholar] [CrossRef] [PubMed]
- Denk, J.; Oberhauser, F.; Kornhuber, J.; Wiltfang, J.; Fassbender, K.; Schroeter, M.L.; Volk, A.E.; Diehl-Schmid, J.; Prudlo, J.; Danek, A.; et al. Specific Serum and CSF MicroRNA Profiles Distinguish Sporadic Behavioural Variant of Frontotemporal Dementia Compared with Alzheimer Patients and Cognitively Healthy Controls. PLoS ONE 2018, 13, e0197329. [Google Scholar] [CrossRef]
- Sheinerman, K.S.; Toledo, J.B.; Tsivinsky, V.G.; Irwin, D.; Grossman, M.; Weintraub, D.; Hurtig, H.I.; Chen-Plotkin, A.; Wolk, D.A.; McCluskey, L.F.; et al. Circulating Brain-Enriched MicroRNAs as Novel Biomarkers for Detection and Differentiation of Neurodegenerative Diseases. Alzheimers. Res. Ther. 2017, 9, 89. [Google Scholar] [CrossRef]
- Derkow, K.; Rössling, R.; Schipke, C.; Krüger, C.; Bauer, J.; Fähling, M.; Stroux, A.; Schott, E.; Ruprecht, K.; Peters, O.; et al. Distinct Expression of the Neurotoxic MicroRNA Family Let-7 in the Cerebrospinal Fluid of Patients with Alzheimer’s Disease. PLoS ONE 2018, 13, e0200602. [Google Scholar] [CrossRef] [Green Version]
- Galimberti, D.; Villa, C.; Fenoglio, C.; Serpente, M.; Ghezzi, L.; Cioffi, S.M.G.; Arighi, A.; Fumagalli, G.; Scarpini, E. Circulating MiRNAs as Potential Biomarkers in Alzheimer’s Disease. J. Alzheimer’s Dis. 2014, 42, 1261–1267. [Google Scholar] [CrossRef]
- Piscopo, P.; Grasso, M.; Puopolo, M.; D’Acunto, E.; Talarico, G.; Crestini, A.; Gasparini, M.; Campopiano, R.; Gambardella, S.; Castellano, A.E.; et al. Circulating MiR-127-3p as a Potential Biomarker for Differential Diagnosis in Frontotemporal Dementia. J. Alzheimers Dis. 2018, 65, 455–464. [Google Scholar] [CrossRef]
- Beckers, J.; Tharkeshwar, A.K.; Van Damme, P. C9orf72 ALS-FTD: Recent Evidence for Dysregulation of the Autophagy-Lysosome Pathway at Multiple Levels. Autophagy 2021, 17, 3306–3322. [Google Scholar] [CrossRef]
- Ryan, S.; Rollinson, S.; Hobbs, E.; Pickering-Brown, S. C9orf72 Dipeptides Disrupt the Nucleocytoplasmic Transport Machinery and Cause TDP-43 Mislocalisation to the Cytoplasm. Sci. Rep. 2022, 12, 4799. [Google Scholar] [CrossRef] [PubMed]
- Davis, S.E.; Roth, J.R.; Aljabi, Q.; Hakim, A.R.; Savell, K.E.; Day, J.J.; Arrant, A.E. Delivering Progranulin to Neuronal Lysosomes Protects against Excitotoxicity. J. Biol. Chem. 2021, 297, 100993. [Google Scholar] [CrossRef] [PubMed]
- Chang, M.C.; Srinivasan, K.; Friedman, B.A.; Suto, E.; Modrusan, Z.; Lee, W.P.; Kaminker, J.S.; Hansen, D.V.; Sheng, M. Progranulin Deficiency Causes Impairment of Autophagy and TDP-43 Accumulation. J. Exp. Med. 2017, 214, 2611–2628. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Sogorb-Esteve, A.; Nilsson, J.; Swift, I.J.; Heller, C.; Bocchetta, M.; Russell, L.L.; Peakman, G.; Convery, R.S.; van Swieten, J.C.; Seelaar, H.; et al. Differential Impairment of Cerebrospinal Fluid Synaptic Biomarkers in the Genetic Forms of Frontotemporal Dementia. Alzheimers. Res. Ther. 2022, 14, 118. [Google Scholar] [CrossRef] [PubMed]
- Forner, S.; Baglietto-Vargas, D.; Martini, A.C.; Trujillo-Estrada, L.; LaFerla, F.M. Synaptic Impairment in Alzheimer’s Disease: A Dysregulated Symphony. Trends Neurosci. 2017, 40, 347–357. [Google Scholar] [CrossRef]
- Mancuso, R.; Agostini, S.; Hernis, A.; Zanzottera, M.; Bianchi, A.; Clerici, M. Circulatory MiR-223-3p Discriminates Between Parkinson’s and Alzheimer’s Patients. Sci. Rep. 2019, 9, 9393. [Google Scholar] [CrossRef] [Green Version]
- Ravnik-Glavač, M.; Glavač, D. Circulating RNAs as Potential Biomarkers in Amyotrophic Lateral Sclerosis. Int. J. Mol. Sci. 2020, 21, 1714. [Google Scholar] [CrossRef] [Green Version]
- Liguori, M.; Nuzziello, N.; Introna, A.; Consiglio, A.; Licciulli, F.; D’Errico, E.; Scarafino, A.; Distaso, E.; Simone, I.L. Dysregulation of MicroRNAs and Target Genes Networks in Peripheral Blood of Patients with Sporadic Amyotrophic Lateral Sclerosis. Front. Mol. Neurosci. 2018, 11, 288. [Google Scholar] [CrossRef]
- Tollervey, J.R.; Curk, T.; Rogelj, B.; Briese, M.; Cereda, M.; Kayikci, M.; König, J.; Hortobágyi, T.; Nishimura, A.L.; Župunski, V.; et al. Characterizing the RNA Targets and Position-Dependent Splicing Regulation by TDP-43. Nat. Neurosci. 2011, 14, 452–458. [Google Scholar] [CrossRef] [Green Version]
- Matsukawa, K.; Kukharsky, M.S.; Park, S.K.; Park, S.; Watanabe, N.; Iwatsubo, T.; Hashimoto, T.; Liebman, S.W.; Shelkovnikova, T.A. Long Non-Coding RNA NEAT1_1 Ameliorates TDP-43 Toxicity in in Vivo Models of TDP-43 Proteinopathy. RNA Biol. 2021, 18, 1546. [Google Scholar] [CrossRef]
- He, L.; Chen, Z.; Wang, J.; Feng, H. Expression Relationship and Significance of NEAT1 and MiR-27a-3p in Serum and Cerebrospinal Fluid of Patients with Alzheimer’s Disease. BMC Neurol. 2022, 22, 203. [Google Scholar] [CrossRef] [PubMed]
- Rascovsky, K.; Hodges, J.R.; Knopman, D.; Mendez, M.F.; Kramer, J.H.; Neuhaus, J.; Van Swieten, J.C.; Seelaar, H.; Dopper, E.G.P.; Onyike, C.U.; et al. Sensitivity of Revised Diagnostic Criteria for the Behavioural Variant of Frontotemporal Dementia. Brain 2011, 134, 2456–2477. [Google Scholar] [CrossRef] [PubMed]
- Livak, K.J.; Schmittgen, T.D. Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method. Methods 2001, 25, 402–408. [Google Scholar] [CrossRef] [PubMed]
- Fan, Y.; Xia, J. MiRNet—Functional Analysis and Visual Exploration of MiRNA–Target Interactions in a Network Context. Methods Mol. Biol. 2018, 1819, 215–233. [Google Scholar] [CrossRef] [PubMed]
- Bleazard, T.; Lamb, J.A.; Griffiths-Jones, S. Bias in MicroRNA Functional Enrichment Analysis. Bioinformatics 2015, 31, 1592–1598. [Google Scholar] [CrossRef]
FTD | Controls | |
---|---|---|
Number of subjects | 32 | 12 |
Gender (M:F) | 20:12 | 7:5 |
Mean age, years ± SD | 72.7 ± 6.2 | 73.2 ± 1.99 |
Mean age at onset, years ± SD | 66.50 ± 0.44 | |
Mean disease duration, years ± SD | 3.01 ± 0.23 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Fenoglio, C.; Serpente, M.; Visconte, C.; Arcaro, M.; Sorrentino, F.; D’Anca, M.; Arighi, A.; Rotondo, E.; Vimercati, R.; Rossi, G.; et al. Circulating Non-Coding RNA Levels Are Altered in Autosomal Dominant Frontotemporal Dementia. Int. J. Mol. Sci. 2022, 23, 14723. https://doi.org/10.3390/ijms232314723
Fenoglio C, Serpente M, Visconte C, Arcaro M, Sorrentino F, D’Anca M, Arighi A, Rotondo E, Vimercati R, Rossi G, et al. Circulating Non-Coding RNA Levels Are Altered in Autosomal Dominant Frontotemporal Dementia. International Journal of Molecular Sciences. 2022; 23(23):14723. https://doi.org/10.3390/ijms232314723
Chicago/Turabian StyleFenoglio, Chiara, Maria Serpente, Caterina Visconte, Marina Arcaro, Federica Sorrentino, Marianna D’Anca, Andrea Arighi, Emanuela Rotondo, Roberto Vimercati, Giacomina Rossi, and et al. 2022. "Circulating Non-Coding RNA Levels Are Altered in Autosomal Dominant Frontotemporal Dementia" International Journal of Molecular Sciences 23, no. 23: 14723. https://doi.org/10.3390/ijms232314723